Home ⟩ Insights

Insights

equities

2 min read • June 24, 2025

Tilray Makes History, First To Import And Sell Branded Medical Cannabis In Italy

6 min read • May 13, 2025

This Cannabis Stock Sits Out The Rally Sparked By US-China Deal

2 min read • March 12, 2025

What’s Going On With Cannabis Firm Tilray Brands Stock On Wednesday?

2 min read • December 20, 2024

Innovative Industrial Properties Hit By Cannabis Company PharmaCann’s Rent Default, Stock Plunges

3 min read • October 23, 2024

AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest

2 min read • May 24, 2024

What’s Going On With Medical Cannabis Company Akanda Stock Friday?

3 min read • April 9, 2024

California’s Underground Marijuana Market Flourishes: Which Companies Remain Resilient Amid Illicit Competition?

2 min read • April 4, 2024

Amazon, Disney, Aurora Cannabis, Paramount Global, Tesla: Why These Stocks Are On Investors’ Radars Today

3 min read • March 28, 2024

Cannabis Producer, Rubicon Organics, Reports Seventh Consecutive Quarter Of Positive Cash Flow & EBITDA

3 min read • March 15, 2024

Cannabis ETF Gains Momentum, Rising Over 8% As DEA Rescheduling Rumors Intensify (UPDATED)

3 min read • March 14, 2024

Green Thumb’s Edge Over S&P 500 & ETFs: Cannabis Investor Confidence Propels Expansion Into Key States

5 min read • February 21, 2024

This Cannabis Stock Is Undervalued, Says Top Analyst: Why Jushi Has An Edge In The Market

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)